LISATA THERAPEUTICS, INC. — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
James Nisco receives a $200,000 gross retention bonus offer, payable by December 31, 2026, contingent on continued employment in good standing and execution of a release of claims. The bonus is forfeited if Nisco resigns or is terminated for Cause before the retention date, but remains payable if terminated without Cause. Payment subject to standard tax withholding and does not affect other separation benefits.
Why this rating
Routine executive retention; $200K is ~0.85% of $23.6M market cap, immaterial. Standard employment contract amendment with no business-changing implications.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.